News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - IPO, Updates
Auris Medical AG (EARS) Announces Exercise Of IPO Over-Allotment Option 8/20/2014
Israeli Biotech Foamix Files For A $75 Million IPO 8/14/2014
San Diego's Otonomy, Inc. (OTIC) Prices Upsized IPO High End Of Range, $16 A Share 8/13/2014
Multiple Sclerosis Biotech Forward Pharma Files For $200 Million IPO 8/12/2014
Tokai Pharmaceuticals, Chasing The Field In Prostate Cancer, Files For $75 Million IPO 8/12/2014
Israel's VBL Therapeutics (VBLX) Terminates NASDAQ IPO Due To Shareholder Mishap 8/12/2014
Bay Area Biotech Firm Tobira Therapeutics Inc. Tables $74 Million IPO 8/11/2014
Early-Stage Biotech Microlin Bio Postpones $28 Million IPO 8/7/2014
Avalanche Biotechnologies (AAVL) Announces Closing Of Initial Public Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 8/5/2014
ContraFect Corporation (CFRXU) Announces Closing Of Initial Public Offering 8/4/2014
Loxo Oncology (LOXO) Prices Upsized IPO At Midpoint Of The Range, $13 A Share 8/1/2014
Ocular Therapeutix, Inc. (OCUL) Announces Closing Of Initial Public Offering 7/31/2014
Innocoll, Inc. (INNL) Announces Closing Of Initial Public Offering 7/31/2014
Catalent, Inc. Announces Pricing of Its Initial Public Offering 7/31/2014
Immune Design Corporation (IMDZ) Announces Closing Of Initial Public Offering 7/30/2014
Intersect ENT Announces Closing Of Its Initial Public Offering 7/30/2014
New York Biotech ContraFect Corporation (CFRXU) Prices Upsized IPO At $5-6 A Share 7/29/2014
Applied Genetic Technologies Corporation Announces Pricing Of Public Offering 7/25/2014
Innocoll AG Announces Pricing Of Initial Public Offering 7/25/2014
Allied Minds Announces Completion Of Its Initial Public Offering And Admission To The London Stock Exchange 7/24/2014
SAGE Therapeutics Announces Closing Of Initial Public Offering 7/23/2014
Orthocell Raises $8 Million In Oversubscribed IPO 7/22/2014
Johnson & Johnson (JNJ) Spinout Zosano Pharma, Inc. Sets Terms For $70 Million IPO 7/18/2014
Luye Pharma Group Ltd. Completes Successful IPO In Hong Kong 7/14/2014
Southern California's Auspex Pharmaceuticals Prices Public Offering, Aims To Raise $60.6 Million 7/11/2014
Luye Pharma Group Ltd. Prices Hong Kong IPO At Top Of Range 7/7/2014
Colorado's GlobeImmune, Inc. (GBIM) Prices IPO At $10 A Share, Below Expectations 7/2/2014
Cambridge's Minerva Neurosciences, Inc. (NERV) Prices IPO Below Range, Debuts At $6 Per Share 7/1/2014
GW Pharmaceuticals Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Totaling Approximately $169.8 Million On The NASDAQ Global Market And Full Exercise Of Underwriters' Option To Purchase Additional Adss 6/26/2014
California's Amphastar Pharmaceuticals, Inc. (AMPH) Prices IPO At $7/Share, Eyes $56 Million 6/26/2014
Zafgen (ZFGN) Announces Closing Of Initial Public Offering And Full Exercise Of Over-Allotment Option 6/25/2014
ZS Pharma (ZSPH) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters’ Over-Allotment Option 6/24/2014
Zafgen (ZFGN) Announces Pricing of Initial Public Offering 6/19/2014
GlaxoSmithKline (GSK) Spin-Off Convergence Pharmaceuticals Gears Up For Possible Listing 6/17/2014
Bay Area's Ardelyx Inc. Lowers IPO Target Slightly, Now Hopes To Raise Up To $62 Million 6/11/2014
Dutch Biotech arGEN-X Plans To Go Public In Brussels 6/10/2014
Akebia Therapeutics, Inc. (AKBA), Trading M&A For An IPO—Becoming A Huge Contender In Anemia Drug Race 6/9/2014
Cancer Biotech Syndax Pharmaceuticals Inc. Sets Terms For $60 Million IPO 6/9/2014
Radius (RDUS) Announces Pricing Of Initial Public Offering 6/6/2014
Orthocell IPO Opens 6/5/2014
New Jersey's Agile Therapeutics, Inc. Prices Downsized IPO At $6 Per Share 5/23/2014
Louisville's GlobeImmune, Inc. Reduces Size Of Proposed IPO 5/22/2014
Third Times The Charm? Radius Recharges IPO After Two Week Hiatus 5/22/2014
For The Second Time In Two Years, Radius Scraps IPO Plans 5/9/2014
Biotech IPO Slump Continues as Alder Biopharmaceuticals Inc. Prices Below Range 5/8/2014
After Three Delays, SCYNEXIS, Inc. (SCYX) Finally Goes IPO At $10 A Share 5/2/2014
Pancreatic Cancer Biotech GlobeImmune, Inc. Sets Terms For $35 Million In Second IPO Attempt 4/30/2014
Massachusett's Zafgen Lines Up $86 Million IPO To Bankroll Obesity Drug Push 4/21/2014
Cerulean Pharma Inc. (CERU) Announces Closing Of Initial Public Offering 4/15/2014
Cerulean Pharma Inc. (CERU) Announces Pricing Of Initial Public Offering 4/10/2014
Emeryville's Adamas Pharmaceuticals (ADMS) IPO Prices At $16, Low End Of Range 4/10/2014
Applied Genetic Technologies Corporation Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/4/2014
Bay Area's Corium International, Inc. Schedules In A $60 Million IPO 4/3/2014
Versartis, Inc. (VSAR) Announces Closing Of Its Initial Public Offering And Full Exercise Of Over-Allottment Option 3/27/2014
MediWound (MDWD) Announces Closing Of Initial Public Offering 3/26/2014
Redwood City Biopharma, Versartis, Inc. (VSAR), Hits High End With $126 Million IPO 3/21/2014
MediWound (MDWD) Prices IPO At $14 Share 3/20/2014
Cambridge's Akebia Therapeutics, Inc. (AKBA) Hauls In $100 Million In Upsized IPO Debut 3/20/2014
Seattle Biotech Alder Biopharmaceuticals Inc. Files For A $115 Million IPO 3/19/2014
Achaogen (AKAO) Announces Closing Of Initial Public Offering And Exercise Of Underwriters' Over-Allotment Option To Purchase Additional Shares 3/18/2014
Galmed Pharmaceuticals Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 3/18/2014
Circassia Limited (CIR.L) Raises $332 Million In IPO Debut, Largest Biotech IPO Since 1995 3/14/2014
New York-Based Dipexium Pharmaceuticals (DPRX) Prices Upsized IPO At $12, Raises $33 Million 3/13/2014
Recro Pharma (REPH) Announces Closing Of Initial Public Offering 3/13/2014
Galmed Pharmaceuticals Debuts Upsized IPO, Raises $38 Million 3/13/2014
Aquinox Pharmaceuticals (AQXP) Announces Closing Of Initial Public Offering 3/12/2014
NeuroVive Pharmaceutical AB: Neurovive Starts Collaboration To Evaluate IPO Of Subsidiary In Taiwan 3/10/2014
Egalet IPO Underwriters Exercise Over-Allotment Option 3/10/2014
Small Biotech Recro Pharma (REPH) Secures A $30 Million IPO Feat 3/7/2014
Durham's SCYNEXIS, Inc. Files For $55 Million IPO 3/3/2014
Revamped Radius Looks To Cash In With $86 Million IPO 2/27/2014
Antibacterial Biotech Achaogen Sets Terms For $65 Million IPO 2/25/2014
Beijing Genomics Institute (BGI) Rumored To Stage $400 Million IPO In Late 2014 2/24/2014
Flexion Therapeutics (FLXN) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 2/19/2014
Concert Pharmaceuticals, Inc. (CNCE) Announces Closing Of Initial Public Offering 2/19/2014
NephroGenex (NRX) Announces Closing Of Initial Public Offering 2/17/2014
Concert Pharmaceuticals, Inc. (CNCE) Heads To Nasdaq, Prices At High End Of The Range 2/13/2014
Eagle Pharmaceuticals (EGRX) Eyes $50 Million In IPO 2/12/2014
ReVance Therapeutics, Inc. (RVNC) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Over-Allotment Option 2/12/2014
Flexion Therapeutics (FLXN) Pulls Off $60 Million In IPO Debut 2/12/2014
Eleven Biotherapeutics (EBIO) Closes Initial Public Offering 2/11/2014
NephroGenex (NRX) Prices IPO At Low End Of Range, Will Reap About $37.2 Million 2/11/2014
uniQure Announces Closing of Initial Public Offering 2/10/2014
Genocea Biosciences Announces Closing Of Initial Public Offering 2/10/2014
Luye Pharma Group Ltd. To Conduct $750 Million Hong Kong IPO 2/10/2014
Argos Therapeutics, Inc. (ARGS) Prices Lower Than Expected IPO, Raises $45 Million 2/7/2014
Eleven Biotherapeutics (EBIO) Prices Downsized IPO, Grabs $50 Million 2/6/2014
Ultragenyx Pharmaceuticals Announces Closing Of Initial Public Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 2/6/2014
Egalet Announces Pricing Of Initial Public Offering 2/6/2014
Circassia Limited Seeks $285 Million In One Of Europe's Biggest Biotech IPOs 2/6/2014
Bay Area's ReVance Therapeutics, Inc. (RVNC) Prices IPO At Top Of Range, Raises $96 Million 2/6/2014
Auspex Pharmaceuticals Announces Pricing Of Initial Public Offering 2/5/2014
uniQure Announces Pricing Of Initial Public Offering 2/5/2014
Seattle Biotech Acucela Inc. Sets Terms Of $162 Million Japanese IPO 2/4/2014
Cara Therapeutics, Inc. (CARA) Scrounges Up $55 Million In Downsized IPO 1/31/2014
CytRx Corporation (CYTR) Announces Proposed Public Offering of Common Stock 1/31/2014
Trevena, Inc. (TRVN) Gives IPO Another Whirl After Postponing Two Months Ago 1/31/2014
Dicerna Pharmaceuticals (DRNA) Prices Upsized IPO At $15 Per Share 1/30/2014
Potential $95 Million Ultragenyx Pharmaceuticals IPO Leads Biotech Class Of '14 1/30/2014
Celladon Corporation Announces Pricing Of Initial Public Offering 1/30/2014
Tesaro, Inc. (TSRO) Announces Proposed Public Offering Of Common Stock 1/29/2014
Zhejiang Wolwo Bio-Pharma Gains 94% Post-IPO 1/27/2014
Gene Therapy Biopharma uniQure Sets Terms For $64 Million IPO 1/27/2014
TaiGen Biotechnology Raises $36 Million In Taiwan IPO 1/20/2014
Jiangsu ASK Pharma Postpones ChiNext IPO 1/13/2014
GlycoMimetics, Inc. (GLYC) Finally Prices Upraised IPO At $8 Per Share 1/10/2014
ReVance Therapeutics, Inc. Files $86.25 Million IPO 1/3/2014
Seattle Biotech Acucela Inc. Seeks $125 Million IPO in Japan to Develop Eye Drugs 12/18/2013
Consun Pharma Schedules Hong Kong IPO 12/13/2013
Kindred Bio (KIN) Prices $52.5 Million IPO For Biopharma Pet R&D 12/12/2013
TetraLogic Pharmaceuticals (TLOG) Slashes Proposed IPO Price To $7, Deal Size Is Now $46 Million 12/12/2013
Karyopharm Therapeutics (KPTI) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares In Its Initial Public Offering 12/11/2013
Xencor Announces Closing Of Initial Public Offering 12/6/2013
Innate Immunotherapeutics Launches IPO To Raise Up To A$12 Million 11/27/2013
San Diego’s Vital Therapies, Inc. (VTI) Postpones IPO As Biotech Sector Cools Off 11/22/2013
Relypsa, Inc. (RLYP) Announces Closing Of Initial Public Offering 11/21/2013
Evogene Ltd. (EVGN) Hauls In $74 Million In IPO 11/21/2013
Relypsa, Inc. (RLYP) Slashes IPO Target Price By Nearly A Third 11/15/2013
GlycoMimetics, Inc. Postpones $60 Million IPO 11/8/2013
Karyopharm Therapeutics (KPTI) Raises $109 Million in Upsized IPO, Begins Trading Today 11/6/2013
Cardiovascular Biotech Celladon Corporation Sets Terms for $75 Million IPO 11/4/2013
Biotech GlobeImmune, Inc. Withdraws $60 Million IPO 11/1/2013
Aerie Pharmaceuticals, Inc. (AERI) Reels in $67 Million in IPO 10/25/2013
ADMA Biologics, Inc. Announces Closing of Initial Public Offering 10/23/2013
Veeva Systems, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 10/21/2013
Late-Stage Biotech Relypsa, Inc. Seeks $138 Million in Upsized IPO 10/18/2013
ADMA Biologics, Inc. Announces Pricing of Initial Public Offering 10/17/2013
MacroGenics, Inc. (MGNX) Hikes Size of Planned IPO to $92 Million 10/10/2013
GlycoMimetics, Inc. Seeks Up to $86 Million in IPO 10/8/2013
Enzymotec Announces Pricing of Its Initial Public Offering 9/27/2013
BIND Therapeutics Announces Closing of Initial Public Offering 9/26/2013
Ophthotech Corporation (OPHT) Reels in $167 Million in IPO 9/25/2013
Foundation Medicine, Inc. (FMI) Lands $106 Million in Upsized IPO 9/25/2013
BIND Therapeutics Scrounges Up $70.5 Million in IPO 9/20/2013
With Support From Celgene (CELG) and Other Investors, Acceleron Pharma Raises $93 Million in IPO 9/19/2013
Sophiris Bio Inc. (SHS.TO) Closes $65 Million Public Offering 8/23/2013
Regado Biosciences, Inc. (RGDO) Finally Goes Public, Raised $43 Million 8/22/2013
Regado Biosciences Downsizes IPO, Seeks $42 Million 8/20/2013
A Quick Glance at the Biotech IPO Boom 8/14/2013
BrainStorm Cell Therapeutics Inc. Announces Pricing of Underwritten Public Offering 8/13/2013
Intrexon Corporation Prices Initial Public Offering 8/8/2013
IntelliPharmaCeutics Closes Public Offering for US$3.1 Million 8/1/2013
Onconova Therapeutics Inc. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option 7/31/2013
Agios Pharmaceuticals Closes Initial Public Offering 7/30/2013
IntelliPharmaCeutics Announces Pricing of Public Offering of Common Shares and Warrants 7/26/2013
Cellular Dynamics International Raises $46 Million in IPO 7/25/2013
Conatus Pharmaceuticals Inc. Announces Pricing of Initial Public Offering 7/25/2013
Onconova Therapeutics Inc. Announces Pricing of Initial Public Offering 7/25/2013
OncoMed Pharmaceuticals, Inc. Announces Closing of Initial Public Offering 7/24/2013
OncoMed Pharmaceuticals, Inc. IPO Rakes in $72 Million 7/18/2013
Heat Biologics Hikes IPO to $33 Million From $24 Million 7/11/2013
Biotech Conatus Pharmaceuticals Inc. Sets Terms for $55 Million IPO 7/10/2013
OncoMed Pharmaceuticals, Inc. Prices IPO at $14-$16 Per Share, Targets $74 Million 7/9/2013
Prosensa Holding N.V. Announces Closing of Initial Public Offering 7/8/2013
ProSensa B.V. Raises $78 Million in IPO 6/28/2013
Esperion Therapeutics, Inc. Prices Upsized $70 Million IPO for Statin Alternative Work 6/27/2013
PTC Therapeutics, Inc. IPO Raises $125 Million Despite Checkered Past 6/20/2013
bluebird bio Prices Upsized IPO Above the Range at $17 6/19/2013
Aratana Therapeutics Postpones $51 Million IPO 6/19/2013
Kadimastem Has Successfully Completed an IPO and Raised $5.5 Million USD 6/10/2013
CSRC Terminates IPO Applications of 15 China Life Science Companies 6/6/2013
Kamada Ltd. (KMDA.TA) Announces Closing of Initial Public Offering and Over-Allotment Option Exercise 6/5/2013
Kamada Ltd. (KMDA.TA) Announces Pricing of Initial Public Offering 6/5/2013
Evoke Pharma, Inc. Files $24 Million IPO 5/31/2013
Epizyme (EPZM) Prices IPO at $15 Per Share, Begins Trading Today 5/31/2013
Portola Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Over-Allotment Option Exercise 5/30/2013
Alcobra Raises $25 Million on NASDAQ 5/29/2013
Ironwood Pharmaceuticals Prices $136.5 Million Stock Offering 5/22/2013
INSYS Therapeutics Completes $37 Million IPO to Back Medical Marijuana Drug 5/21/2013
Ambit Biosciences Cuts IPO Price 5/16/2013
Quintiles, Inc. (QTRN)'s $947.4M IPO to Spawn a New Billionaire 5/10/2013
Quintiles, Inc. (QTRN) Celebrates IPO on the New York Stock Exchange 5/10/2013
Receptos Announces Pricing of Initial Public Offering of Common Stock 5/9/2013
INSYS Therapeutics Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option 5/7/2013
San Diego's Receptos, Ambit Biosciences, Get Ready for IPO Debuts 5/7/2013
INSYS Therapeutics Announces Pricing of IPO 5/2/2013
TPG-Backed Quintiles, Inc. (QTRN) Outlines $790 Million Price in IPO 4/26/2013
Omthera Pharmaceuticals, Inc. Prices Upsized IPO Below the Range at $8 4/11/2013
Harvard Apparatus Postpones $19 Million IPO 4/10/2013
Chimerix, Inc. Sets Terms for $85 Million IPO 4/2/2013
Enanta Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option 3/27/2013
Enanta Pharmaceuticals, Inc. Raises $56 Million in IPO 3/21/2013
Zoetis (ZTS) Closes Initial Public Offering 2/7/2013
KaloBios Pharmaceuticals, Inc. Completes Initial Public Offering 2/7/2013
Stemline Therapeutics, Inc. (STML) Announces Closing of Initial Public Offering 2/1/2013
Pfizer Inc. (PFE)'s Zoetis (ZTS) Hauls in $2.24 Billion in IPO 2/1/2013
Stemline Therapeutics, Inc. (STML) Rises in Its Market Debut as First Biotech IPO of 2013 1/30/2013
KaloBios Pharmaceuticals, Inc. on Path Toward $50 Million IPO 1/28/2013
Vantiv Succeeds With IPO, Begins Rapid Acquisitions 12/28/2012
Cancer Drug Spinoff of Australian Company, Audeo Oncology Inc. Preps $49 Million IPO 12/10/2012
Puma Biotechnology Raises $138 Million in Public Offering of Common Stock 10/26/2012
BioIndustry Association Release: Latest French Biotech IPO Demonstrates the Potential of Citizens' Innovation Funds 10/25/2012
ImmunoCellular Therapeutics, Ltd Announces Pricing of its Previously Announced Public Offering of Common Stock and Warrants 10/18/2012
Anacor Pharmaceuticals, Inc. Prices $24 Million Public Offering of Common Stock 10/18/2012
MannKind Corporation (MNKD) Prices Offering at 23 Pct Discount 10/18/2012
Kythera Biopharmaceuticals Announces Closing of Initial Public Offering and Exercise of Underwriters’ Over-Allotment Option 10/16/2012
Intercept Pharmaceuticals, Kythera Biopharmaceuticals Take Off in IPOs 10/12/2012
Intercept Pharmaceuticals Announces Pricing of Initial Public Offering 10/11/2012
Kythera Biopharmaceuticals Announces Pricing of Initial Public Offering 10/11/2012
Isis Pharmaceuticals, Inc. (ISIS) Investment in Regulus Therapeutics, Inc. Valued at $28 Million at Completion of Regulus Initial Public Offering 10/11/2012



//-->